These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33565445)

  • 1. Thrombotic microangiopathy in a renal allograft: Single-center five-year experience.
    Vanikar AV; Kanodia KV; Suthar KS; Nigam LA; Patel RD; Thakkar UG; Mehta AH
    Saudi J Kidney Dis Transpl; 2020; 31(6):1331-1343. PubMed ID: 33565445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
    Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
    Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Early Thrombotic Microangiopathy in Renal Transplantation.
    Mour GK; Ninan J; Butterfield D; Zhang N; Nair SS; Smith M; Ryan M; Reddy K; Heilman RL
    Clin Transplant; 2024 Jul; 38(7):e15373. PubMed ID: 39023085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathy.
    Carson JM; Newman ED; Farber JL; Filippone EJ
    Clin Nephrol; 2012 Jan; 77(1):79-84. PubMed ID: 22185974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection.
    Satoskar AA; Pelletier R; Adams P; Nadasdy GM; Brodsky S; Pesavento T; Henry M; Nadasdy T
    Am J Transplant; 2010 Aug; 10(8):1804-11. PubMed ID: 20659088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine-associated thrombotic microangiopathy in renal allografts.
    Zarifian A; Meleg-Smith S; O'donovan R; Tesi RJ; Batuman V
    Kidney Int; 1999 Jun; 55(6):2457-66. PubMed ID: 10354295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated arterial mucoid intimal thickening lesion in early post-transplant kidney allograft biopsies.
    Kitamura M; Doraiswamy M; Parkinson B; Yenebre P; Ibrahim D; Dasgupta A; Tyagi A; Nori U; Nadasdy T; Rajab A; Brodsky SV; Satoskar AA
    Clin Transplant; 2023 Sep; 37(9):e15007. PubMed ID: 37170811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.
    Takeda A; Ohtsuka Y; Horike K; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():15-8. PubMed ID: 21623908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile and outcomes of
    Saikumar Doradla LP; Lal H; Kaul A; Bhaduaria D; Jain M; Prasad N; Thammishetti V; Gupta A; Patel M; Sharma RK
    Saudi J Kidney Dis Transpl; 2020; 31(1):160-168. PubMed ID: 32129209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.
    Meehan SM; Kremer J; Ali FN; Curley J; Marino S; Chang A; Kadambi PV
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):395-403. PubMed ID: 20966124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical-pathological correlations in post-transplant thrombotic microangiopathy.
    Broecker V; Bardsley V; Torpey N; Perera R; Montero R; Dorling A; Bentall A; Neil D; Willicombe M; Berry M; Roufosse C
    Histopathology; 2019 Jul; 75(1):88-103. PubMed ID: 30851188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.
    Aoun B; Decramer S; Vitkevic R; Wannous H; Bandin F; Azema C; Callard P; Brocheriou I; Ulinski T
    Pediatr Nephrol; 2013 Mar; 28(3):493-8. PubMed ID: 23111894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.
    Sreedharanunni S; Joshi K; Duggal R; Nada R; Minz M; Sakhuja V
    Transpl Int; 2014 Aug; 27(8):784-92. PubMed ID: 24684170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of progressive thrombotic microangiopathy after ABO-incompatible renal transplantation.
    Miura M; Fujita H; Suzuki A; Kubota KC; Fukasawa Y; Shimoda N; Tsuchihashi S; Tamaki T
    Clin Transplant; 2011 Jul; 25 Suppl 23():19-22. PubMed ID: 21623909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus.
    Cortina G; Trojer R; Waldegger S; Schneeberger S; Gut N; Hofer J
    Pediatr Nephrol; 2015 Apr; 30(4):693-7. PubMed ID: 25577332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo thrombotic microangiopathy after kidney transplantation in adults: Interplay between complement genetics and multiple endothelial injury.
    Dessaix K; Bontoux C; Aubert O; Grünenwald A; Sberro Soussan R; Zuber J; Duong Van Huyen JP; Anglicheau D; Legendre C; Fremeaux Bacchi V; Rabant M
    Am J Transplant; 2024 Jul; 24(7):1205-1217. PubMed ID: 38320731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
    Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y
    Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.
    Woodle ES; Cronin D; Newell KA; Millis JM; Bruce DS; Piper JB; Haas M; Josephson MA; Thistlethwaite JR
    Transplantation; 1996 Oct; 62(7):906-10. PubMed ID: 8878382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.